Clinical trial
HPV Testing for Cervical Cancer Screening Study
NCT00461760 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00461760 |
|---|---|
| Title | HPV Testing for Cervical Cancer Screening Study |
| Official title | A Randomized Controlled Evaluation of HPV Testing for Cervical Cancer Screening |
| Acronym | HPVFOCAL |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cervical Cancer Screening |
| Intervention type | Procedure |
| Interventions | Cervical cancer screening undertaken by HPV testing as a single primary screening test with cytology triage of women who are HPV positive |
| Enrollment | 25,223 |
| Start date | Mar 1, 2007 |
| Primary completion | Apr 30, 2017 |
| Completion | Jun 30, 2018 |
| First posted | Apr 18, 2007 |
| Last update posted | Jun 19, 2019 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: